The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
about
Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditionsGuidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Von Willebrand factor-cleaving protease activity remains at the intermediate level in thrombotic thrombocytopenic purpura.Thrombotic thrombocytopenic purpura and its diagnosis.The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency.Evaluation and management of patients with thrombotic thrombocytopenic purpura.The homozygous leu variant of the factor XIII Val34Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies.Clinical cardiac involvement in thrombotic thrombocytopenic purpura: a systematic review.Twice-daily plasma exchange for patients with refractory thrombotic thrombocytopenic purpura: the experience of the Oklahoma Registry, 1989 through 2006.The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: the Swiss connection.Sporadic bloody diarrhoea-associated thrombotic thrombocytopenic purpura-haemolytic uraemic syndrome: an adult and paediatric comparison.Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies?The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study.The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies.Clinical features of severe acquired ADAMTS13 deficiency in thrombotic thrombocytopenic purpura: the Korean TTP registry experience.A report of disseminated adenocarcinoma presenting as thrombotic thrombocytopenic purpura.Attending rounds: microangiopathic hemolytic anemia with renal insufficiencyThrombotic microangiopathy: current knowledge and outcomes with plasma exchange.Causes and risk factors of death in patients with thrombotic microangiopathies.Platelet recovery rate during plasma exchange predicts early and late responses in patients with thrombotic thrombocytopenic purpura.Cyclosporin A therapy on idiopathic thrombotic thrombocytopenic purpura in the relapse setting: two case reports and a review of the literature.Thrombotic thrombocytopenic purpura (TTP)-like illness associated with intravenous Opana ER abuse--Tennessee, 2012.Management and outcomes for patients with TTP: analysis of 100 cases at a single institution.Von Willebrand factor-cleaving protease activity in thrombotic microangiopathy: first report from iranRe-examination of 30-day survival and relapse rates in patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Acquired thrombotic thrombocytopenic purpura: new therapeutic options and their optimal use.The thrombotic microangiopathy Registry of North America: A United States multi-institutional TMA network.Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia.Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.Thrombotic microangiopathy in haematopoietic cell transplantation: an update.Conventional apheresis therapies: a review.An Atypical Presentation of Chronic Atrophic Gastritis: Hemolytic Anemia and Mesenteric Panniculitis.Acute cholecystitis in thrombotic thrombocytopenic purpura.Complications of plasma exchange in patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.Tibor Greenwalt Award. The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: a program for patient care, education and research.Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
P2860
Q28267403-5DED2E16-D06C-485D-A095-A4F7DA092EC7Q30276550-4223B526-F1B7-4210-A7FD-6CF8CBBAEDACQ30441694-67BA7330-D592-439D-ACC5-26B11C1C70B6Q33361758-F76A0590-12D7-47A8-B61E-F6FA62DBAD2DQ33366113-C4B587D3-39A5-4299-A4C8-DCB9E434CF9AQ33366296-E07778E0-15F3-4D32-80FD-0058F207C006Q33366935-3C6CB2B6-FB52-4865-A340-E8C2CA256A60Q33375004-0C717F1E-4B69-446A-A171-2EB8B8EC45D6Q33376809-FB6AC1D4-50EE-4564-AB3F-0972DF2BA81DQ33377495-8A90F6E5-95CD-4273-A8B7-638CF8761375Q33377500-350A8FA3-A4E1-4B12-8A12-5A9EF1F879E3Q33378414-307BADB8-CFCB-4DCB-B0ED-F9A5AAE635BBQ33379319-83188DDC-65E8-480B-98DC-212D44410B27Q33379731-6B7930EB-96CF-4612-ADD0-3785184E4A51Q33384532-912A6D57-658C-4E32-A15B-314C24B0080DQ33384534-EFC72CCE-FFFF-4972-96D6-0E38D79F66ABQ33393950-F25B5CAB-768F-4F58-B01F-CF9C848AF889Q33398812-613AAF03-E0C9-47BB-8F74-A4E063D6CF38Q33398895-F5C57F84-D32D-49FC-94C3-F8D00FEB4CF9Q33399520-512BCF2D-FC17-431F-9E8B-360620F9F93EQ33402347-1C6796F3-7C5B-4E06-B5A2-96EDE8F92CE4Q33402876-EA381B3B-352E-4145-A12E-A51B85731B0DQ33404199-6DACF461-2B4E-44A5-BDC2-E3C4AC76203AQ33405202-A06BA171-D346-45CD-BA0A-9B2D2E34D899Q33407187-E94F86C3-203B-4E94-8FAE-387125AF7D9DQ33420881-D16F53D7-16BB-4319-9E29-73FFDBC5CB92Q33423051-70FD0BB7-734F-492F-B122-CAA4C185880BQ33424183-97EBEC5A-2C77-4BF6-8334-CCB314988865Q33427586-5D8712EA-EBDF-43B3-9D08-2DFCD82DB551Q33438377-C0146892-FDB5-403E-BC6D-A298E5B25594Q34122035-A2F20E64-757B-4C95-B05E-53BA8E81CA35Q35098992-588223A8-7055-47E8-957A-C32243F0F772Q37924701-8E57BDA1-EB62-49EF-8E91-F6413F8ED18EQ41025601-4DB13AC0-7870-4E8F-A2F5-58C52686BDC1Q42938492-0B185B4B-5F01-4871-B311-0CC6857806DFQ43834946-A6DC82D7-D289-494D-8338-762B17C53F83Q48348303-764CCDA8-2B4D-4F77-867E-7DC5D2F0063EQ52576561-A71F53EE-89A7-4F3A-AB04-6F3A4B03CBB3
P2860
The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: a community perspective of patients with clinically diagnosed TTP-HUS.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@ast
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@en
type
label
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@ast
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@en
prefLabel
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@ast
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@en
P921
P1476
The Oklahoma Thrombotic Thromb ...... clinically diagnosed TTP-HUS.
@en
P2093
James N George
P356
10.1053/J.SEMINHEMATOL.2003.10.001
P577
2004-01-01T00:00:00Z